Liesbeth Van Wesenbeeck

Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.

Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.

Journal: Clinical pharmacology and therapeutics
Published: April 02, 2026

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Journal: The New England journal of medicine
Published: November 26, 2025

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.

Journal: The New England journal of medicine
Published: November 26, 2025

Evaluating dengue transmission dynamics in an endemic urban setting in Viet Nam: an index-household contact cohort study.

Evaluating dengue transmission dynamics in an endemic urban setting in Viet Nam: an index-household contact cohort study.

Journal: The Lancet. Infectious diseases
Published: August 27, 2025

A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia.

A Prospective Cohort Study of Primary Dengue Virus Infection in Medellín, Colombia.

Journal: Vaccines
Published: June 12, 2025

Dengue Infections Among Household Contacts of Symptomatic Index Cases: Implications for Community-Based Intervention Studies.

Dengue Infections Among Household Contacts of Symptomatic Index Cases: Implications for Community-Based Intervention Studies.

Journal: Viruses
Published: May 23, 2025

Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis.

Quantifying temporal differences in the induction of interferon-mediated signalling observed in a dengue virus 1 human infection model: insights from longitudinal proteome analysis.

Journal: EBioMedicine
Published: September 18, 2024

Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab.

Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab.

Journal: Scientific reports
Published: May 10, 2024

The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19.

The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19.

Journal: The Journal of infection
Published: February 20, 2024

Evolution of inflammation and immunity in a dengue virus 1 human infection model.

Evolution of inflammation and immunity in a dengue virus 1 human infection model.

Journal: Science translational medicine
Published: October 26, 2022

Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.

Blocking NS3-NS4B interaction inhibits dengue virus in non-human primates.

Journal: Nature
Published: June 29, 2022

A phylogenetic study of dengue virus in urban Vietnam shows long-term persistence of endemic strains.

A phylogenetic study of dengue virus in urban Vietnam shows long-term persistence of endemic strains.

Journal: Virus evolution
Published: March 09, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026